Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000921895-25-000092·AEON Biopharma, Inc.
Schedule 13G ownership disclosure
AEON Biopharma, Inc.
Common Stock, $.0001 par value · CUSIP: 00791X100
Event date: 2025-01-06
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIGGER CAPITAL FUND L P
Shares: 2,450,000.00 · Class: 3.1%
- Bigger Capital Fund GP, LLC
Shares: 2,450,000.00 · Class: 3.1%
- District 2 Capital Fund LP
Shares: 2,450,000.00 · Class: 3.1%
- District 2 Capital LP
Shares: 2,450,000.00 · Class: 3.1%
- District 2 GP LLC
Shares: 2,450,000.00 · Class: 3.1%
- District 2 Holdings LLC
Shares: 2,450,000.00 · Class: 3.1%
- Bigger Michael
Shares: 4,900,000.00 · Class: 6.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-000092
- Form type
- SCHEDULE 13G
- Filer
- AEON Biopharma, Inc.
- CIK
- CIK 1837607
- Filed
- Jan 08, 2025
- Reporting period
- Jan 06, 2025
- Description
- Schedule 13G beneficial ownership